Dehydroepiandrosterone replacement in women with adrenal insufficiency: Effects on body composition, serum leptin, bone turnover, and exercise capacity

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 5, 2001, Pages 1968-1972

  Callies, Frank ^a   Fassnacht, Martin ^a   Van Vlijmen, Jan Christoph ^a   Koehler, Ines ^a   Huebler, Doris ^b   Seibel, Markus J ^c   Arlt, Wiebke ^a   Allolio, Bruno ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b BAYER PHARMA AG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LEPTIN; PRASTERONE;

ADRENAL INSUFFICIENCY; ADULT; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY MASS; BONE TURNOVER; CARBOHYDRATE METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EXERCISE; FEMALE; HUMAN; IMPEDANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANIMALIA;

EID: 0034999978     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.5.7483     Document Type: Article

References (34)

1. Wright BE, Svec F, Porter JR. 1995 Central effects of dehydroepiandrosterone in Zucker rats. Int J Obes Relat Metab Disord. 19:887-892.
2. Coleman DL, Leiter EH, Schwizer RW. 1982 Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes. 31:830-833.
3. Coleman DL, Leiter EH, Schwizer RW. 1982 Therapeutic effects of dehydroepiandrosterone (DHEA) and its metabolites in obese hyperglycemic mutant mice. Prog Clin Biol Res. 265:161-165.
4. Nestler JE, Barlascini CO, Clore JN, Blackard WG. 1988 Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab.ol. 66:57-61.
5. Mortola JF, Yen SSC. 1990 The effect of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab. 71:696-704.
6. Welle S, Jozefowicz R, Statt M. 1990 Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans. J Clin Endocrinol Metab. 71:1259-1264.
7. Morales AJ, Nolan JJ, Nelson JC, Yen SSC. 1994 Effects of replacement dose of dehydroepiandrosterone in men and women of advanced age. J Clin Endocrinol Metab. 78:1360-1367.
8. Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS. 1998 The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol (Oxf). 49:421-432.
9. Yen SSC, Morales AJ, Khorram O. 1995 Replacement of DHEA in aging men and women. Potential remedial effects. Ann NY Acad Sci. 774:128-142.
10. Diamond P, Cusan L, Gomez J-L, Bélanger A, Labrie F. 1996 Metabolic effects of 12-months percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J Endocrinol. 150:43-50.
11. Arlt W, Callies F, van Vlijmen JC, et al. 1999 Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med. 341:1013-1020.
12. Seibel MJ, Duncan A, Robins SP. 1989 Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic disease. J Rheumatol. 16:964-970.
13. Kotler DP, Rosenbaum K, Allison DB, Wang J, Pierson Jr RN. 1999 Validation of bioimpedance analysis as a measure of change in body cell mass as estimated by whole-body counting of potassium in adults. J Parenter Enteral Nutr. 23:345-349.
14. Abu Khaled M, McCutcheon MJ, Reddy S, Pearman PL, Hunter GR, Weinsier RL. 1988 Electrical impedance in assessing human body composition: the BIA method. Am J Clin Nutr. 47:789-792.
15. Beshyah SA, Freemantle C, Thomas E, Johnston DG. 1995 Comparison of measurements of body composition by total potassium, bioimpedance analysis, and dual-energy x-ray absorptiometry in hypopituitary adults before and during growth hormone treatment. Am J Clin Nutr. 61:1186-1194.
16. Wallenstein S, Fisher AC. 1977 Statistical analysis of two-period repeated measurements crossover designs. Biometrics. 33:261-269.
17. Yen TT, Allaw JA, Pearson DV, Acton JM, Greenberg MM. 1977 Prevention of obesity in Avy/a mice by dehydroepiandrosterone. Lipids. 12:409-413.
18. Tagliaferro AR, Davis JR, Truchon S, Van Hamont N. 1986 Effects of dehydroepiandrosterone acetate on metabolism, body weight and composition of male and female rats. J Nutr. 116:1977-1983.
19. Cutler Jr GB, Glenn M, Bush M, Hodgen GD, Graham CE, Loriaux DL. 1978 Adrenarche: a survey of rodents, domestic animals, and primates. Endocrinology. 103:2112-2118.
20. Considine RV, Sinha MK, Heiman ML, et al. 1996 Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med. 334:292-295.
21. Maffei M, Halaas J, Ravussin E, et al. 1995 Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1:1155-1161.
22. Saad MF, Damani S, Gingerich RL, et al. 1997 Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab. 82:579-584.
23. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M. 1996 Radioimmunoassay of leptin in human plasma. Clin Chem. 42:942-946.
24. Rosenbaum M, Nicolson M, Hirsch J, et al. 1996 Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab. 81:3424-3427.
25. Elbers JMH, Asscheman H, Seidell JC, Fröhlich M, AE M, Gooren LJG. 1997 Reversal of the sex differences in serum leptin levels upon cross-sex hormone administration in transsexuals. J Clin Endocrinol Metab. 82:3267-3270.
26. Jockenhövel F, Blum WF, Vogel E, et al. 1997 Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men. J Clin Endocrinol Metab. 82:2510-2513.
27. Xu X, De Pergola G, Björntorp P. 1990 The effects of androgens on the regulation of lipolysis in adipose precursor cells. Endocrinology. 126: 1229-1234.
28. Sjögren J, Li M, Björntorp P. 1995 Androgen hormone binding to adipose tissue. Biochim Biophys Acta. 1244:117-120.
29. Baulieu EE, Thomas G, Legrain S, et al. 2000 Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci USA. 97:4279-4284.
30. Gordon CM, Grace E, Emans SJ, Goodman E, Crawford MH, Leboff MS. 1999 Changes in bone turnover markers and menstrual function after short-term oral DHEA in young women with anorexia nervosa. J Bone Miner Res. 14:136-145.
31. Massafra C, De Felice C, Agnusdei DP, Gioia D, Bagnoli F. 1999 Androgens and osteocalcin during the menstrual cycle. J Clin Endocrinol Metab. 84:971-974.
32. Mauras N, Hayes VY, Vieira NE, Yergey AL, O'Brien KO. 1999 Profound hypogonadism has significant negative effects on calcium balance in males: a calcium kinetic study. J Bone Miner Res. 14:577-582.
33. Kasperk CH, Wakley GK, Hierl T, Ziegler R. 1997 Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro. J Bone Miner Res. 12:464-471.
34. 3) to stimulate human osteoblastic cell differentiation. Life Sci. 62:59-68.